What 2026 Tells Us About 2027: Five Cannabis Trends to Plan Around

Operators went into 2026 expecting relief. A First Citizens and Whitney Economics survey found nearly 87% expected revenue growth. Over ten months in, some relief has arrived for some, pricing pressure has arrived for everyone, and federal rules are still catching up. Here are five trends to build your 2027 budget around.

1. Price compression sets your margin

MJBiz Factbook data shows U.S. sales fell from $32 billion to $29.94 billion in 2025, the first decline on record. Demand held. Prices did not. In Michigan, retailers sold 348 million units for $3.17 billion in 2025, compared with 291 million units for $3.38 billion in an earlier period. By my math, revenue per unit fell about 22%.

Rent, labor, debt payments, and taxes did not fall by 22%. So review gross margin by product after discounts, not by store. A 20% discount on a product with a 50% margin means you must sell 67% more units to earn the same gross profit. Year end is a great time to closely review your product margins, selling price and consider adjusting your product mix.

2. The tax picture now has two tracks

Medical operators got 280E relief for tax years starting in 2026. Adult-use operators did not, and the DEA’s broader rescheduling hearing closed in July with no decision date. If you hold both license types, you must split shared costs between the two, and the IRS has not issued guidance on how.

More help may be coming. The Treasury and IRS added guidance under Section 280E to a priority plan that runs through September 30, 2027. This is some of the first official guidance that the IRS will issue regarding cannabis under 280E specifically. But a plan is not a deadline. So plan 2027 taxes on today’s rules, set and document your allocation methods before you file, and treat any refund as upside you have not yet earned.

3. Banking and capital access have not caught up

Rescheduling did not fix banking. Card networks have not announced policy changes in response. Congress reintroduced the SAFE Banking Act in June, but it has not passed the full Senate. As of July 1, banking regulators had not issued cannabis-specific guidance after the rescheduling order. That means most operators should plan as if nothing has changed, even if you’re a medical license holder.

That shows up in your costs. Cash handling, security, and high-risk payment fees are line items you can measure, so compare what you pay across banks and processors. Don’t plan on the institutional lender pool growing before broader rescheduling, so price your interest and borrowing costs in the 2027 budget on today’s terms.

4. Headcount is under pressure, AI might help

Legal cannabis lost jobs for the first time, and operators in California and Michigan cut labor costs and ran leaner as oversupply and new taxes squeezed margins. Savings from 280E relief will likely shift into compliance, tax strategy, and advisory costs for medical operators, so budget for those before you count the savings as profit.

Treat every new hire as an investment you have to justify in 2027, even the entry level ones. Before you post a job, write down the hours of work behind it and what happens if you leave it unfilled. Track revenue per employee and labor as a percentage of revenue by location. Then look at repetitive work first: reporting, reconciliations, inventory counts, and scheduling.

Some operators now use AI for that work, but not to replace existing headcount. In an mg Magazine report, operators described using it for forecasts, sales analysis, and reports, with no layoffs. The CEO of Sinful said it has kept the company from needing to hire, not shrunk the team. You can’t audit a hire that never happened, so test it. Pick one workflow, record the hours before, and compare after an AI process has been implemented. Check every output, because AI can be wrong with confidence, and keep customer, employee, and license data out of public AI tools. Use AI to identify opportunities to limit future hiring before you consider replacing your existing team.

5. Debt funds the industry, and deals follow distress

Debt was about 94.8% of capital raised by U.S. licensed operators in 2025, and most of it refinanced existing loans instead of funding growth. In the first quarter of 2026, debt was over 90% of capital raised worldwide, and equity totaled just $94.2 million. About $6 billion in sector debt comes due by the end of 2026.

M&A rose alongside it. Disclosed deal value reached $579.7 million in the first quarter, up from $38.3 million a year earlier, with distressed and court-supervised deals in the mix. Some multi-state operators are selling non-core licenses and stores to satisfy lenders.

Expect more of that in 2027. Viridian says large institutional capital likely needs banking reform first, so plan on debt, not equity. When does your next loan mature? Know your maturity dates and covenants now, and open refinancing talks early. Interest is generally a tax deduction, but not for adult-use operators under 280E. Medical operators can start taking that deduction for tax years 2026 and forward. And if you might buy or sell, keep revenue, inventory, intercompany, and allocation records ready for a buyer’s review, especially if you hold a dual use license.

What to do before the year closes

Start with inventory. Count it, age it, and write down anything you can no longer sell for more than it cost. Inventory is generally carried at the lower of cost or what you can sell it for. Then rebuild your 2027 budget with average selling prices 10% below today’s and see what breaks. If that number scares you, November is the time to find out.

Next, put your allocation method in writing if you hold both license types, and tag transactions by license type from here forward. Build two tax scenarios: one on today’s rules, and one projecting the future guidance that may arrive. Then track three numbers every month: gross margin by category, revenue per unit, and sales per labor hour.

KEY TAKEAWAY

Price compression, a split tax regime, slow banking reform, and debt-heavy capital markets define the year ahead. Build your 2027 budget on today’s rules and today’s prices, stress-test it, and treat any relief as upside.


About the author

Melissa Diaz, CPA, is a co-owner and partner of High Rock Accounting, a CPA firm providing outsourced accounting, fractional CFO services, and tax strategy to cannabis and peptide operators. She was named a 2026 Forbes Best-in-State CPA.

Questions about how this affects your business? Talk to our team at highrock.co/contact

This article is for general information and is not tax or legal advice.


Enjoyed this article? Consider Sharing

Author

Melissa Diaz

Melissa Diaz

Melissa Diaz is a Partner and Chief Revenue Officer at High Rock Accounting, where she leads the firm's cannabis vertical. With deep expertise in the unique financial and tax complexities facing cannabis operators — including 280E, multi-entity structures, and industry-specific software — Melissa works closely with growth-stage companies navigating one of the most regulated industries in the country. She's passionate about helping cannabis businesses build financial infrastructure that actually scales.

want to see how high rock can streamline your accounting?

Explor more insights

stay ahead with high rock insights

Subscribe to our High Rock Insights newsletter below.
© Copyright 2025 High Rock Accounting